nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—NR3C1—hematologic cancer	0.0795	1	CbGaD
Fluocinonide—Dexamethasone—hematologic cancer	0.0741	0.336	CrCtD
Fluocinonide—Betamethasone—hematologic cancer	0.0741	0.336	CrCtD
Fluocinonide—Triamcinolone—hematologic cancer	0.0724	0.328	CrCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—hematologic cancer	0.0719	0.209	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—hematologic cancer	0.0719	0.209	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—hematologic cancer	0.0694	0.202	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—hematologic cancer	0.0672	0.195	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—hematologic cancer	0.0635	0.185	CiPCiCtD
Fluocinonide—SERPINA6—Triamcinolone—hematologic cancer	0.0289	0.269	CbGbCtD
Fluocinonide—SERPINA6—Prednisolone—hematologic cancer	0.0245	0.228	CbGbCtD
Fluocinonide—NR3C1—Triamcinolone—hematologic cancer	0.0135	0.126	CbGbCtD
Fluocinonide—NR3C1—Betamethasone—hematologic cancer	0.0116	0.108	CbGbCtD
Fluocinonide—NR3C1—Prednisolone—hematologic cancer	0.0114	0.106	CbGbCtD
Fluocinonide—NR3C1—Prednisone—hematologic cancer	0.0108	0.1	CbGbCtD
Fluocinonide—NR3C1—Dexamethasone—hematologic cancer	0.00674	0.0627	CbGbCtD
Fluocinonide—Fluticasone furoate—Dexamethasone—hematologic cancer	0.00213	0.012	CrCrCtD
Fluocinonide—Fluticasone furoate—Betamethasone—hematologic cancer	0.00213	0.012	CrCrCtD
Fluocinonide—Fluticasone furoate—Triamcinolone—hematologic cancer	0.00208	0.0118	CrCrCtD
Fluocinonide—Ciclesonide—Prednisone—hematologic cancer	0.00205	0.0116	CrCrCtD
Fluocinonide—Ciclesonide—Prednisolone—hematologic cancer	0.00201	0.0113	CrCrCtD
Fluocinonide—Flurandrenolide—Betamethasone—hematologic cancer	0.00198	0.0112	CrCrCtD
Fluocinonide—Flurandrenolide—Dexamethasone—hematologic cancer	0.00198	0.0112	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Dexamethasone—hematologic cancer	0.00191	0.0108	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Betamethasone—hematologic cancer	0.00191	0.0108	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Triamcinolone—hematologic cancer	0.00187	0.0106	CrCrCtD
Fluocinonide—Halobetasol Propionate—Dexamethasone—hematologic cancer	0.00185	0.0105	CrCrCtD
Fluocinonide—Halobetasol Propionate—Betamethasone—hematologic cancer	0.00185	0.0105	CrCrCtD
Fluocinonide—Fluticasone Propionate—Dexamethasone—hematologic cancer	0.00185	0.0105	CrCrCtD
Fluocinonide—Fluticasone Propionate—Betamethasone—hematologic cancer	0.00185	0.0105	CrCrCtD
Fluocinonide—Difluprednate—Betamethasone—hematologic cancer	0.00185	0.0105	CrCrCtD
Fluocinonide—Difluprednate—Dexamethasone—hematologic cancer	0.00185	0.0105	CrCrCtD
Fluocinonide—Halobetasol Propionate—Triamcinolone—hematologic cancer	0.00181	0.0102	CrCrCtD
Fluocinonide—Difluprednate—Triamcinolone—hematologic cancer	0.00181	0.0102	CrCrCtD
Fluocinonide—Fluticasone Propionate—Triamcinolone—hematologic cancer	0.00181	0.0102	CrCrCtD
Fluocinonide—Flurandrenolide—Prednisolone—hematologic cancer	0.00179	0.0101	CrCrCtD
Fluocinonide—Beclomethasone—Betamethasone—hematologic cancer	0.00174	0.00985	CrCrCtD
Fluocinonide—Beclomethasone—Dexamethasone—hematologic cancer	0.00174	0.00985	CrCrCtD
Fluocinonide—Clocortolone—Dexamethasone—hematologic cancer	0.00174	0.00985	CrCrCtD
Fluocinonide—Clocortolone—Betamethasone—hematologic cancer	0.00174	0.00985	CrCrCtD
Fluocinonide—Beclomethasone—Triamcinolone—hematologic cancer	0.0017	0.00962	CrCrCtD
Fluocinonide—Clocortolone—Triamcinolone—hematologic cancer	0.0017	0.00962	CrCrCtD
Fluocinonide—Fluocortolone—Betamethasone—hematologic cancer	0.00169	0.00957	CrCrCtD
Fluocinonide—Fluocortolone—Dexamethasone—hematologic cancer	0.00169	0.00957	CrCrCtD
Fluocinonide—Fluocortolone—Triamcinolone—hematologic cancer	0.00165	0.00935	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Betamethasone—hematologic cancer	0.00165	0.0093	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Dexamethasone—hematologic cancer	0.00165	0.0093	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Triamcinolone—hematologic cancer	0.00161	0.00909	CrCrCtD
Fluocinonide—Budesonide—Betamethasone—hematologic cancer	0.0016	0.00905	CrCrCtD
Fluocinonide—Amcinonide—Dexamethasone—hematologic cancer	0.0016	0.00905	CrCrCtD
Fluocinonide—Amcinonide—Betamethasone—hematologic cancer	0.0016	0.00905	CrCrCtD
Fluocinonide—Budesonide—Dexamethasone—hematologic cancer	0.0016	0.00905	CrCrCtD
Fluocinonide—Beclomethasone—Prednisolone—hematologic cancer	0.00158	0.00892	CrCrCtD
Fluocinonide—Clocortolone—Prednisolone—hematologic cancer	0.00158	0.00892	CrCrCtD
Fluocinonide—Fluocortolone—Prednisone—hematologic cancer	0.00157	0.00887	CrCrCtD
Fluocinonide—Budesonide—Triamcinolone—hematologic cancer	0.00156	0.00885	CrCrCtD
Fluocinonide—Amcinonide—Triamcinolone—hematologic cancer	0.00156	0.00885	CrCrCtD
Fluocinonide—Flunisolide—Dexamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Desonide—Dexamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Clobetasol propionate—Betamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Diflorasone—Dexamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Clobetasol propionate—Dexamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Flunisolide—Betamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Diflorasone—Betamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Desonide—Betamethasone—hematologic cancer	0.00156	0.00882	CrCrCtD
Fluocinonide—Fluocortolone—Prednisolone—hematologic cancer	0.00153	0.00866	CrCrCtD
Fluocinonide—Diflorasone—Triamcinolone—hematologic cancer	0.00152	0.00862	CrCrCtD
Fluocinonide—Flunisolide—Triamcinolone—hematologic cancer	0.00152	0.00862	CrCrCtD
Fluocinonide—Desonide—Triamcinolone—hematologic cancer	0.00152	0.00862	CrCrCtD
Fluocinonide—Clobetasol propionate—Triamcinolone—hematologic cancer	0.00152	0.00862	CrCrCtD
Fluocinonide—Paramethasone—Dexamethasone—hematologic cancer	0.00152	0.0086	CrCrCtD
Fluocinonide—Paramethasone—Betamethasone—hematologic cancer	0.00152	0.0086	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Prednisolone—hematologic cancer	0.00149	0.00842	CrCrCtD
Fluocinonide—Paramethasone—Triamcinolone—hematologic cancer	0.00149	0.0084	CrCrCtD
Fluocinonide—Amcinonide—Prednisone—hematologic cancer	0.00149	0.0084	CrCrCtD
Fluocinonide—Budesonide—Prednisone—hematologic cancer	0.00149	0.0084	CrCrCtD
Fluocinonide—Desoximetasone—Dexamethasone—hematologic cancer	0.00148	0.00839	CrCrCtD
Fluocinonide—Desoximetasone—Betamethasone—hematologic cancer	0.00148	0.00839	CrCrCtD
Fluocinonide—Desoximetasone—Triamcinolone—hematologic cancer	0.00145	0.0082	CrCrCtD
Fluocinonide—Budesonide—Prednisolone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Amcinonide—Prednisolone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Mometasone—Dexamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Mometasone—Betamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Triamcinolone—Dexamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Fluorometholone—Betamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Fluorometholone—Dexamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Dexamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Betamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Triamcinolone—Betamethasone—hematologic cancer	0.00145	0.00819	CrCrCtD
Fluocinonide—Desonide—Prednisone—hematologic cancer	0.00145	0.00818	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisone—hematologic cancer	0.00145	0.00818	CrCrCtD
Fluocinonide—Flunisolide—Prednisone—hematologic cancer	0.00145	0.00818	CrCrCtD
Fluocinonide—Diflorasone—Prednisone—hematologic cancer	0.00145	0.00818	CrCrCtD
Fluocinonide—Rimexolone—Dexamethasone—hematologic cancer	0.00142	0.008	CrCrCtD
Fluocinonide—Dexamethasone—Betamethasone—hematologic cancer	0.00142	0.008	CrCrCtD
Fluocinonide—Rimexolone—Betamethasone—hematologic cancer	0.00142	0.008	CrCrCtD
Fluocinonide—Betamethasone—Dexamethasone—hematologic cancer	0.00142	0.008	CrCrCtD
Fluocinonide—Fluorometholone—Triamcinolone—hematologic cancer	0.00142	0.008	CrCrCtD
Fluocinonide—Mometasone—Triamcinolone—hematologic cancer	0.00142	0.008	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Triamcinolone—hematologic cancer	0.00142	0.008	CrCrCtD
Fluocinonide—Desonide—Prednisolone—hematologic cancer	0.00141	0.00798	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisolone—hematologic cancer	0.00141	0.00798	CrCrCtD
Fluocinonide—Diflorasone—Prednisolone—hematologic cancer	0.00141	0.00798	CrCrCtD
Fluocinonide—Flunisolide—Prednisolone—hematologic cancer	0.00141	0.00798	CrCrCtD
Fluocinonide—Paramethasone—Prednisone—hematologic cancer	0.00141	0.00797	CrCrCtD
Fluocinonide—Dexamethasone—Triamcinolone—hematologic cancer	0.00138	0.00782	CrCrCtD
Fluocinonide—Rimexolone—Triamcinolone—hematologic cancer	0.00138	0.00782	CrCrCtD
Fluocinonide—Betamethasone—Triamcinolone—hematologic cancer	0.00138	0.00782	CrCrCtD
Fluocinonide—Paramethasone—Prednisolone—hematologic cancer	0.00138	0.00778	CrCrCtD
Fluocinonide—Desoximetasone—Prednisone—hematologic cancer	0.00138	0.00778	CrCrCtD
Fluocinonide—Methylprednisolone—Betamethasone—hematologic cancer	0.00135	0.00766	CrCrCtD
Fluocinonide—Methylprednisolone—Dexamethasone—hematologic cancer	0.00135	0.00766	CrCrCtD
Fluocinonide—Fluorometholone—Prednisone—hematologic cancer	0.00134	0.0076	CrCrCtD
Fluocinonide—Triamcinolone—Prednisone—hematologic cancer	0.00134	0.0076	CrCrCtD
Fluocinonide—Mometasone—Prednisone—hematologic cancer	0.00134	0.0076	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisone—hematologic cancer	0.00134	0.0076	CrCrCtD
Fluocinonide—Desoximetasone—Prednisolone—hematologic cancer	0.00134	0.00759	CrCrCtD
Fluocinonide—Methylprednisolone—Triamcinolone—hematologic cancer	0.00132	0.00748	CrCrCtD
Fluocinonide—Dexamethasone—Prednisone—hematologic cancer	0.00131	0.00742	CrCrCtD
Fluocinonide—Rimexolone—Prednisone—hematologic cancer	0.00131	0.00742	CrCrCtD
Fluocinonide—Betamethasone—Prednisone—hematologic cancer	0.00131	0.00742	CrCrCtD
Fluocinonide—Fluorometholone—Prednisolone—hematologic cancer	0.00131	0.00741	CrCrCtD
Fluocinonide—Mometasone—Prednisolone—hematologic cancer	0.00131	0.00741	CrCrCtD
Fluocinonide—Triamcinolone—Prednisolone—hematologic cancer	0.00131	0.00741	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisolone—hematologic cancer	0.00131	0.00741	CrCrCtD
Fluocinonide—Rimexolone—Prednisolone—hematologic cancer	0.00128	0.00724	CrCrCtD
Fluocinonide—Betamethasone—Prednisolone—hematologic cancer	0.00128	0.00724	CrCrCtD
Fluocinonide—Dexamethasone—Prednisolone—hematologic cancer	0.00128	0.00724	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisone—hematologic cancer	0.00126	0.0071	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisolone—hematologic cancer	0.00123	0.00693	CrCrCtD
Fluocinonide—SMO—lung—hematologic cancer	0.000539	0.138	CbGeAlD
Fluocinonide—SERPINA6—hematopoietic system—hematologic cancer	0.000511	0.13	CbGeAlD
Fluocinonide—SMO—testis—hematologic cancer	0.000509	0.13	CbGeAlD
Fluocinonide—SMO—lymph node—hematologic cancer	0.000369	0.0941	CbGeAlD
Fluocinonide—SERPINA6—blood—hematologic cancer	0.000339	0.0864	CbGeAlD
Fluocinonide—SERPINA6—bone marrow—hematologic cancer	0.000328	0.0836	CbGeAlD
Fluocinonide—SERPINA6—lung—hematologic cancer	0.000297	0.0758	CbGeAlD
Fluocinonide—NR3C1—hematopoietic system—hematologic cancer	0.000224	0.0571	CbGeAlD
Fluocinonide—NR3C1—gonad—hematologic cancer	0.00017	0.0434	CbGeAlD
Fluocinonide—NR3C1—blood—hematologic cancer	0.000148	0.0379	CbGeAlD
Fluocinonide—NR3C1—bone marrow—hematologic cancer	0.000143	0.0366	CbGeAlD
Fluocinonide—NR3C1—lung—hematologic cancer	0.00013	0.0332	CbGeAlD
Fluocinonide—NR3C1—testis—hematologic cancer	0.000123	0.0313	CbGeAlD
Fluocinonide—NR3C1—lymph node—hematologic cancer	8.89e-05	0.0227	CbGeAlD
Fluocinonide—Difluprednate—NR3C1—hematologic cancer	5.89e-05	0.0563	CrCbGaD
Fluocinonide—Clocortolone—NR3C1—hematologic cancer	5.71e-05	0.0546	CrCbGaD
Fluocinonide—Desonide—NR3C1—hematologic cancer	5.41e-05	0.0517	CrCbGaD
Fluocinonide—Diflorasone—NR3C1—hematologic cancer	5.41e-05	0.0517	CrCbGaD
Fluocinonide—Desoximetasone—NR3C1—hematologic cancer	5.27e-05	0.0504	CrCbGaD
Fluocinonide—Flurandrenolide—NR3C1—hematologic cancer	4.62e-05	0.0441	CrCbGaD
Fluocinonide—Flumethasone Pivalate—NR3C1—hematologic cancer	4.54e-05	0.0434	CrCbGaD
Fluocinonide—Halobetasol Propionate—NR3C1—hematologic cancer	4.47e-05	0.0427	CrCbGaD
Fluocinonide—Budesonide—NR3C1—hematologic cancer	4.15e-05	0.0397	CrCbGaD
Fluocinonide—Amcinonide—NR3C1—hematologic cancer	4.15e-05	0.0397	CrCbGaD
Fluocinonide—Fluticasone furoate—NR3C1—hematologic cancer	4.07e-05	0.0389	CrCbGaD
Fluocinonide—Mometasone—NR3C1—hematologic cancer	3.95e-05	0.0377	CrCbGaD
Fluocinonide—Rimexolone—NR3C1—hematologic cancer	3.9e-05	0.0373	CrCbGaD
Fluocinonide—Beclomethasone—NR3C1—hematologic cancer	3.68e-05	0.0352	CrCbGaD
Fluocinonide—Fluocinolone Acetonide—NR3C1—hematologic cancer	3.58e-05	0.0342	CrCbGaD
Fluocinonide—Flunisolide—NR3C1—hematologic cancer	3.48e-05	0.0333	CrCbGaD
Fluocinonide—Clobetasol propionate—NR3C1—hematologic cancer	3.48e-05	0.0333	CrCbGaD
Fluocinonide—Paramethasone—NR3C1—hematologic cancer	3.44e-05	0.0329	CrCbGaD
Fluocinonide—Ciclesonide—NR3C1—hematologic cancer	3.38e-05	0.0323	CrCbGaD
Fluocinonide—Fluorometholone—NR3C1—hematologic cancer	3.36e-05	0.0321	CrCbGaD
Fluocinonide—Methylprednisolone—NR3C1—hematologic cancer	3.25e-05	0.031	CrCbGaD
Fluocinonide—Pruritus—Imatinib—hematologic cancer	3.02e-05	0.000697	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—hematologic cancer	3.01e-05	0.000694	CcSEcCtD
Fluocinonide—Skin disorder—Thalidomide—hematologic cancer	3e-05	0.000692	CcSEcCtD
Fluocinonide—Hyperglycaemia—Betamethasone—hematologic cancer	2.99e-05	0.000691	CcSEcCtD
Fluocinonide—Hyperglycaemia—Dexamethasone—hematologic cancer	2.99e-05	0.000691	CcSEcCtD
Fluocinonide—Rash—Procarbazine—hematologic cancer	2.99e-05	0.000689	CcSEcCtD
Fluocinonide—Dermatitis—Procarbazine—hematologic cancer	2.99e-05	0.000689	CcSEcCtD
Fluocinonide—Headache—Procarbazine—hematologic cancer	2.97e-05	0.000685	CcSEcCtD
Fluocinonide—Pruritus—Cladribine—hematologic cancer	2.97e-05	0.000685	CcSEcCtD
Fluocinonide—Hypersensitivity—Vinblastine—hematologic cancer	2.96e-05	0.000684	CcSEcCtD
Fluocinonide—Infection—Carmustine—hematologic cancer	2.95e-05	0.00068	CcSEcCtD
Fluocinonide—Rash—Dasatinib—hematologic cancer	2.93e-05	0.000676	CcSEcCtD
Fluocinonide—Rash—Bexarotene—hematologic cancer	2.93e-05	0.000676	CcSEcCtD
Fluocinonide—Pain—Bortezomib—hematologic cancer	2.93e-05	0.000675	CcSEcCtD
Fluocinonide—Dermatitis—Dasatinib—hematologic cancer	2.93e-05	0.000675	CcSEcCtD
Fluocinonide—Dermatitis—Bexarotene—hematologic cancer	2.93e-05	0.000675	CcSEcCtD
Fluocinonide—Rash—Fludarabine—hematologic cancer	2.92e-05	0.000674	CcSEcCtD
Fluocinonide—Dermatitis—Fludarabine—hematologic cancer	2.92e-05	0.000673	CcSEcCtD
Fluocinonide—Infection—Alitretinoin—hematologic cancer	2.92e-05	0.000673	CcSEcCtD
Fluocinonide—Immune system disorder—Etoposide—hematologic cancer	2.92e-05	0.000673	CcSEcCtD
Fluocinonide—Headache—Bexarotene—hematologic cancer	2.91e-05	0.000671	CcSEcCtD
Fluocinonide—Headache—Dasatinib—hematologic cancer	2.91e-05	0.000671	CcSEcCtD
Fluocinonide—Pain—Bleomycin—hematologic cancer	2.91e-05	0.00067	CcSEcCtD
Fluocinonide—Headache—Fludarabine—hematologic cancer	2.9e-05	0.00067	CcSEcCtD
Fluocinonide—Infection—Ifosfamide—hematologic cancer	2.88e-05	0.000665	CcSEcCtD
Fluocinonide—Nervous system disorder—Alitretinoin—hematologic cancer	2.88e-05	0.000665	CcSEcCtD
Fluocinonide—Pain—Vinorelbine—hematologic cancer	2.86e-05	0.000659	CcSEcCtD
Fluocinonide—Skin disorder—Alitretinoin—hematologic cancer	2.85e-05	0.000658	CcSEcCtD
Fluocinonide—Nervous system disorder—Ifosfamide—hematologic cancer	2.85e-05	0.000657	CcSEcCtD
Fluocinonide—Dizziness—Nilotinib—hematologic cancer	2.84e-05	0.000655	CcSEcCtD
Fluocinonide—Dizziness—Imatinib—hematologic cancer	2.82e-05	0.000651	CcSEcCtD
Fluocinonide—Skin disorder—Ifosfamide—hematologic cancer	2.82e-05	0.000651	CcSEcCtD
Fluocinonide—Hypersensitivity—Melphalan—hematologic cancer	2.82e-05	0.00065	CcSEcCtD
Fluocinonide—Infection—Vincristine—hematologic cancer	2.81e-05	0.000649	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—hematologic cancer	2.78e-05	0.000642	CcSEcCtD
Fluocinonide—Nervous system disorder—Vincristine—hematologic cancer	2.78e-05	0.00064	CcSEcCtD
Fluocinonide—Dizziness—Cladribine—hematologic cancer	2.77e-05	0.00064	CcSEcCtD
Fluocinonide—Erythema—Prednisolone—hematologic cancer	2.77e-05	0.000639	CcSEcCtD
Fluocinonide—Hypersensitivity—Lenalidomide—hematologic cancer	2.74e-05	0.000632	CcSEcCtD
Fluocinonide—Infection—Irinotecan—hematologic cancer	2.74e-05	0.000632	CcSEcCtD
Fluocinonide—Infection—Mitoxantrone—hematologic cancer	2.74e-05	0.000632	CcSEcCtD
Fluocinonide—Triamcinolone—NR3C1—hematologic cancer	2.74e-05	0.0261	CrCbGaD
Fluocinonide—Pain—Thiotepa—hematologic cancer	2.73e-05	0.00063	CcSEcCtD
Fluocinonide—Pruritus—Melphalan—hematologic cancer	2.71e-05	0.000624	CcSEcCtD
Fluocinonide—Rash—Nilotinib—hematologic cancer	2.71e-05	0.000624	CcSEcCtD
Fluocinonide—Dermatitis—Nilotinib—hematologic cancer	2.7e-05	0.000624	CcSEcCtD
Fluocinonide—Nervous system disorder—Irinotecan—hematologic cancer	2.7e-05	0.000624	CcSEcCtD
Fluocinonide—Hypersensitivity—Hydroxyurea—hematologic cancer	2.7e-05	0.000623	CcSEcCtD
Fluocinonide—Rash—Imatinib—hematologic cancer	2.69e-05	0.000621	CcSEcCtD
Fluocinonide—Headache—Nilotinib—hematologic cancer	2.69e-05	0.00062	CcSEcCtD
Fluocinonide—Dermatitis—Imatinib—hematologic cancer	2.69e-05	0.00062	CcSEcCtD
Fluocinonide—Skin disorder—Mitoxantrone—hematologic cancer	2.68e-05	0.000618	CcSEcCtD
Fluocinonide—Headache—Imatinib—hematologic cancer	2.67e-05	0.000617	CcSEcCtD
Fluocinonide—Infection—Gemcitabine—hematologic cancer	2.67e-05	0.000615	CcSEcCtD
Fluocinonide—Dizziness—Vinblastine—hematologic cancer	2.66e-05	0.000614	CcSEcCtD
Fluocinonide—Rash—Cladribine—hematologic cancer	2.64e-05	0.00061	CcSEcCtD
Fluocinonide—Dermatitis—Cladribine—hematologic cancer	2.64e-05	0.00061	CcSEcCtD
Fluocinonide—Pain—Thalidomide—hematologic cancer	2.64e-05	0.000609	CcSEcCtD
Fluocinonide—Nervous system disorder—Gemcitabine—hematologic cancer	2.63e-05	0.000608	CcSEcCtD
Fluocinonide—Pruritus—Lenalidomide—hematologic cancer	2.63e-05	0.000607	CcSEcCtD
Fluocinonide—Headache—Cladribine—hematologic cancer	2.63e-05	0.000606	CcSEcCtD
Fluocinonide—Skin disorder—Gemcitabine—hematologic cancer	2.61e-05	0.000602	CcSEcCtD
Fluocinonide—Hyperglycaemia—Prednisone—hematologic cancer	2.61e-05	0.000601	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—hematologic cancer	2.59e-05	0.000598	CcSEcCtD
Fluocinonide—Erythema—Triamcinolone—hematologic cancer	2.55e-05	0.000588	CcSEcCtD
Fluocinonide—Pain—Carmustine—hematologic cancer	2.54e-05	0.000585	CcSEcCtD
Fluocinonide—Hypersensitivity—Bortezomib—hematologic cancer	2.52e-05	0.000582	CcSEcCtD
Fluocinonide—Headache—Vinblastine—hematologic cancer	2.52e-05	0.000581	CcSEcCtD
Fluocinonide—Pain—Alitretinoin—hematologic cancer	2.51e-05	0.00058	CcSEcCtD
Fluocinonide—Hypersensitivity—Bleomycin—hematologic cancer	2.5e-05	0.000577	CcSEcCtD
Fluocinonide—Infection—Cisplatin—hematologic cancer	2.49e-05	0.000574	CcSEcCtD
Fluocinonide—Pain—Ifosfamide—hematologic cancer	2.48e-05	0.000573	CcSEcCtD
Fluocinonide—Hypersensitivity—Vinorelbine—hematologic cancer	2.46e-05	0.000568	CcSEcCtD
Fluocinonide—Dizziness—Lenalidomide—hematologic cancer	2.46e-05	0.000568	CcSEcCtD
Fluocinonide—Nervous system disorder—Cisplatin—hematologic cancer	2.45e-05	0.000566	CcSEcCtD
Fluocinonide—Fluticasone Propionate—NR3C1—hematologic cancer	2.45e-05	0.0234	CrCbGaD
Fluocinonide—Skin disorder—Cisplatin—hematologic cancer	2.43e-05	0.000561	CcSEcCtD
Fluocinonide—Dizziness—Hydroxyurea—hematologic cancer	2.43e-05	0.00056	CcSEcCtD
Fluocinonide—Pruritus—Bortezomib—hematologic cancer	2.42e-05	0.000559	CcSEcCtD
Fluocinonide—Pain—Vincristine—hematologic cancer	2.42e-05	0.000558	CcSEcCtD
Fluocinonide—Rash—Melphalan—hematologic cancer	2.41e-05	0.000557	CcSEcCtD
Fluocinonide—Dermatitis—Melphalan—hematologic cancer	2.41e-05	0.000556	CcSEcCtD
Fluocinonide—Pruritus—Bleomycin—hematologic cancer	2.4e-05	0.000554	CcSEcCtD
Fluocinonide—Dry skin—Epirubicin—hematologic cancer	2.4e-05	0.000553	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—hematologic cancer	2.38e-05	0.000548	CcSEcCtD
Fluocinonide—Pruritus—Vinorelbine—hematologic cancer	2.36e-05	0.000546	CcSEcCtD
Fluocinonide—Pain—Irinotecan—hematologic cancer	2.36e-05	0.000544	CcSEcCtD
Fluocinonide—Pain—Mitoxantrone—hematologic cancer	2.36e-05	0.000544	CcSEcCtD
Fluocinonide—Hypersensitivity—Thiotepa—hematologic cancer	2.35e-05	0.000543	CcSEcCtD
Fluocinonide—Rash—Lenalidomide—hematologic cancer	2.35e-05	0.000541	CcSEcCtD
Fluocinonide—Dermatitis—Lenalidomide—hematologic cancer	2.34e-05	0.000541	CcSEcCtD
Fluocinonide—Nasopharyngitis—Epirubicin—hematologic cancer	2.34e-05	0.00054	CcSEcCtD
Fluocinonide—Headache—Lenalidomide—hematologic cancer	2.33e-05	0.000538	CcSEcCtD
Fluocinonide—Rash—Hydroxyurea—hematologic cancer	2.31e-05	0.000534	CcSEcCtD
Fluocinonide—Erythema—Betamethasone—hematologic cancer	2.31e-05	0.000533	CcSEcCtD
Fluocinonide—Erythema—Dexamethasone—hematologic cancer	2.31e-05	0.000533	CcSEcCtD
Fluocinonide—Dermatitis—Hydroxyurea—hematologic cancer	2.31e-05	0.000533	CcSEcCtD
Fluocinonide—Headache—Hydroxyurea—hematologic cancer	2.3e-05	0.00053	CcSEcCtD
Fluocinonide—Pain—Gemcitabine—hematologic cancer	2.3e-05	0.00053	CcSEcCtD
Fluocinonide—Infection—Etoposide—hematologic cancer	2.28e-05	0.000526	CcSEcCtD
Fluocinonide—Hypersensitivity—Thalidomide—hematologic cancer	2.27e-05	0.000525	CcSEcCtD
Fluocinonide—Dizziness—Bortezomib—hematologic cancer	2.26e-05	0.000522	CcSEcCtD
Fluocinonide—Pruritus—Thiotepa—hematologic cancer	2.26e-05	0.000521	CcSEcCtD
Fluocinonide—Betamethasone—NR3C1—hematologic cancer	2.24e-05	0.0214	CrCbGaD
Fluocinonide—Skin disorder—Etoposide—hematologic cancer	2.23e-05	0.000514	CcSEcCtD
Fluocinonide—Dry skin—Doxorubicin—hematologic cancer	2.22e-05	0.000512	CcSEcCtD
Fluocinonide—Dizziness—Vinorelbine—hematologic cancer	2.21e-05	0.00051	CcSEcCtD
Fluocinonide—Hypersensitivity—Carmustine—hematologic cancer	2.18e-05	0.000504	CcSEcCtD
Fluocinonide—Pruritus—Thalidomide—hematologic cancer	2.18e-05	0.000504	CcSEcCtD
Fluocinonide—Hypersensitivity—Alitretinoin—hematologic cancer	2.16e-05	0.000499	CcSEcCtD
Fluocinonide—Nasopharyngitis—Doxorubicin—hematologic cancer	2.16e-05	0.000499	CcSEcCtD
Fluocinonide—Rash—Bortezomib—hematologic cancer	2.16e-05	0.000498	CcSEcCtD
Fluocinonide—Dermatitis—Bortezomib—hematologic cancer	2.16e-05	0.000498	CcSEcCtD
Fluocinonide—Headache—Bortezomib—hematologic cancer	2.14e-05	0.000495	CcSEcCtD
Fluocinonide—Rash—Bleomycin—hematologic cancer	2.14e-05	0.000494	CcSEcCtD
Fluocinonide—Pain—Cisplatin—hematologic cancer	2.14e-05	0.000494	CcSEcCtD
Fluocinonide—Dermatitis—Bleomycin—hematologic cancer	2.14e-05	0.000494	CcSEcCtD
Fluocinonide—Hypersensitivity—Ifosfamide—hematologic cancer	2.14e-05	0.000493	CcSEcCtD
Fluocinonide—Dizziness—Thiotepa—hematologic cancer	2.11e-05	0.000487	CcSEcCtD
Fluocinonide—Rash—Vinorelbine—hematologic cancer	2.11e-05	0.000486	CcSEcCtD
Fluocinonide—Dermatitis—Vinorelbine—hematologic cancer	2.11e-05	0.000486	CcSEcCtD
Fluocinonide—Headache—Vinorelbine—hematologic cancer	2.09e-05	0.000483	CcSEcCtD
Fluocinonide—Immune system disorder—Prednisone—hematologic cancer	2.09e-05	0.000482	CcSEcCtD
Fluocinonide—Hypersensitivity—Vincristine—hematologic cancer	2.09e-05	0.000481	CcSEcCtD
Fluocinonide—Pruritus—Alitretinoin—hematologic cancer	2.08e-05	0.000479	CcSEcCtD
Fluocinonide—Infection—Triamcinolone—hematologic cancer	2.07e-05	0.000477	CcSEcCtD
Fluocinonide—Pruritus—Ifosfamide—hematologic cancer	2.05e-05	0.000474	CcSEcCtD
Fluocinonide—Dizziness—Thalidomide—hematologic cancer	2.04e-05	0.000471	CcSEcCtD
Fluocinonide—Hyperglycaemia—Epirubicin—hematologic cancer	2.04e-05	0.00047	CcSEcCtD
Fluocinonide—Hypersensitivity—Irinotecan—hematologic cancer	2.03e-05	0.000469	CcSEcCtD
Fluocinonide—Hypersensitivity—Mitoxantrone—hematologic cancer	2.03e-05	0.000469	CcSEcCtD
Fluocinonide—Erythema—Prednisone—hematologic cancer	2.01e-05	0.000465	CcSEcCtD
Fluocinonide—Rash—Thiotepa—hematologic cancer	2.01e-05	0.000464	CcSEcCtD
Fluocinonide—Dermatitis—Thiotepa—hematologic cancer	2.01e-05	0.000464	CcSEcCtD
Fluocinonide—Headache—Thiotepa—hematologic cancer	2e-05	0.000461	CcSEcCtD
Fluocinonide—Fluticasone furoate—ABCB1—hematologic cancer	1.96e-05	0.0188	CrCbGaD
Fluocinonide—Dizziness—Carmustine—hematologic cancer	1.96e-05	0.000452	CcSEcCtD
Fluocinonide—Pain—Etoposide—hematologic cancer	1.96e-05	0.000452	CcSEcCtD
Fluocinonide—Rash—Thalidomide—hematologic cancer	1.95e-05	0.000449	CcSEcCtD
Fluocinonide—Dermatitis—Thalidomide—hematologic cancer	1.95e-05	0.000449	CcSEcCtD
Fluocinonide—Dizziness—Alitretinoin—hematologic cancer	1.94e-05	0.000448	CcSEcCtD
Fluocinonide—Headache—Thalidomide—hematologic cancer	1.93e-05	0.000446	CcSEcCtD
Fluocinonide—Pain—Prednisolone—hematologic cancer	1.93e-05	0.000446	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—JUN—hematologic cancer	1.93e-05	0.000835	CbGpPWpGaD
Fluocinonide—Dizziness—Ifosfamide—hematologic cancer	1.92e-05	0.000443	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOS—hematologic cancer	1.92e-05	0.000828	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL2—hematologic cancer	1.91e-05	0.000827	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREB1—hematologic cancer	1.91e-05	0.000827	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAK3—hematologic cancer	1.91e-05	0.000823	CbGpPWpGaD
Fluocinonide—Pruritus—Gemcitabine—hematologic cancer	1.9e-05	0.000438	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—FOS—hematologic cancer	1.9e-05	0.00082	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CREB1—hematologic cancer	1.89e-05	0.000818	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Doxorubicin—hematologic cancer	1.89e-05	0.000435	CcSEcCtD
Fluocinonide—Infection—Dexamethasone—hematologic cancer	1.87e-05	0.000433	CcSEcCtD
Fluocinonide—Infection—Betamethasone—hematologic cancer	1.87e-05	0.000433	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CXCR4—hematologic cancer	1.87e-05	0.000809	CbGpPWpGaD
Fluocinonide—Dizziness—Vincristine—hematologic cancer	1.87e-05	0.000432	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.87e-05	0.000808	CbGpPWpGaD
Fluocinonide—Rash—Carmustine—hematologic cancer	1.87e-05	0.000431	CcSEcCtD
Fluocinonide—Dermatitis—Carmustine—hematologic cancer	1.87e-05	0.000431	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—hematologic cancer	1.86e-05	0.000805	CbGpPWpGaD
Fluocinonide—Headache—Carmustine—hematologic cancer	1.86e-05	0.000429	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—NCOR1—hematologic cancer	1.85e-05	0.000801	CbGpPWpGaD
Fluocinonide—Rash—Alitretinoin—hematologic cancer	1.85e-05	0.000427	CcSEcCtD
Fluocinonide—Nervous system disorder—Dexamethasone—hematologic cancer	1.85e-05	0.000427	CcSEcCtD
Fluocinonide—Nervous system disorder—Betamethasone—hematologic cancer	1.85e-05	0.000427	CcSEcCtD
Fluocinonide—Dermatitis—Alitretinoin—hematologic cancer	1.85e-05	0.000427	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—hematologic cancer	1.85e-05	0.000797	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Cisplatin—hematologic cancer	1.84e-05	0.000425	CcSEcCtD
Fluocinonide—Headache—Alitretinoin—hematologic cancer	1.84e-05	0.000425	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—hematologic cancer	1.83e-05	0.000792	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AR—hematologic cancer	1.83e-05	0.000792	CbGpPWpGaD
Fluocinonide—Rash—Ifosfamide—hematologic cancer	1.83e-05	0.000422	CcSEcCtD
Fluocinonide—Dermatitis—Ifosfamide—hematologic cancer	1.83e-05	0.000422	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—MAPK8—hematologic cancer	1.83e-05	0.00079	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR7—hematologic cancer	1.83e-05	0.000789	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL13—hematologic cancer	1.83e-05	0.000789	CbGpPWpGaD
Fluocinonide—Dizziness—Irinotecan—hematologic cancer	1.82e-05	0.000421	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.81e-05	0.000782	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—FOXO1—hematologic cancer	1.81e-05	0.000781	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL3—hematologic cancer	1.81e-05	0.00078	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCOR2—hematologic cancer	1.8e-05	0.000779	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IFNG—hematologic cancer	1.79e-05	0.000773	CbGpPWpGaD
Fluocinonide—Rash—Vincristine—hematologic cancer	1.78e-05	0.000412	CcSEcCtD
Fluocinonide—Dermatitis—Vincristine—hematologic cancer	1.78e-05	0.000411	CcSEcCtD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—EP300—hematologic cancer	1.78e-05	0.00077	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL3RA—hematologic cancer	1.78e-05	0.000769	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CRKL—hematologic cancer	1.78e-05	0.000769	CbGpPWpGaD
Fluocinonide—Pain—Triamcinolone—hematologic cancer	1.78e-05	0.00041	CcSEcCtD
Fluocinonide—Headache—Vincristine—hematologic cancer	1.77e-05	0.000409	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—RASGRP1—hematologic cancer	1.75e-05	0.000755	CbGpPWpGaD
Fluocinonide—Immune system disorder—Methotrexate—hematologic cancer	1.75e-05	0.000403	CcSEcCtD
Fluocinonide—Rash—Irinotecan—hematologic cancer	1.74e-05	0.000401	CcSEcCtD
Fluocinonide—Rash—Mitoxantrone—hematologic cancer	1.74e-05	0.000401	CcSEcCtD
Fluocinonide—Dermatitis—Irinotecan—hematologic cancer	1.74e-05	0.000401	CcSEcCtD
Fluocinonide—Dermatitis—Mitoxantrone—hematologic cancer	1.74e-05	0.000401	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—RARA—hematologic cancer	1.73e-05	0.000749	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—SRC—hematologic cancer	1.73e-05	0.000749	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—EP300—hematologic cancer	1.73e-05	0.000747	CbGpPWpGaD
Fluocinonide—Headache—Irinotecan—hematologic cancer	1.73e-05	0.000398	CcSEcCtD
Fluocinonide—Headache—Mitoxantrone—hematologic cancer	1.73e-05	0.000398	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—RGS2—hematologic cancer	1.72e-05	0.000742	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	1.7e-05	0.000393	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—CMA1—hematologic cancer	1.7e-05	0.000734	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TRH—hematologic cancer	1.7e-05	0.000734	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TRIO—hematologic cancer	1.7e-05	0.000734	CbGpPWpGaD
Fluocinonide—Rash—Gemcitabine—hematologic cancer	1.69e-05	0.000391	CcSEcCtD
Fluocinonide—Dermatitis—Gemcitabine—hematologic cancer	1.69e-05	0.00039	CcSEcCtD
Fluocinonide—Hypersensitivity—Etoposide—hematologic cancer	1.69e-05	0.00039	CcSEcCtD
Fluocinonide—Erythema—Methotrexate—hematologic cancer	1.68e-05	0.000388	CcSEcCtD
Fluocinonide—Headache—Gemcitabine—hematologic cancer	1.68e-05	0.000388	CcSEcCtD
Fluocinonide—Hypersensitivity—Prednisolone—hematologic cancer	1.67e-05	0.000384	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—FAS—hematologic cancer	1.66e-05	0.000718	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AGO2—hematologic cancer	1.66e-05	0.000718	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPHK1—hematologic cancer	1.66e-05	0.000718	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HDAC9—hematologic cancer	1.64e-05	0.000711	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LPAR1—hematologic cancer	1.64e-05	0.000711	CbGpPWpGaD
Fluocinonide—Immune system disorder—Epirubicin—hematologic cancer	1.63e-05	0.000377	CcSEcCtD
Fluocinonide—Infection—Prednisone—hematologic cancer	1.63e-05	0.000377	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—H3F3B—hematologic cancer	1.63e-05	0.000703	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN1B—hematologic cancer	1.62e-05	0.000702	CbGpPWpGaD
Fluocinonide—Pruritus—Etoposide—hematologic cancer	1.62e-05	0.000374	CcSEcCtD
Fluocinonide—Pain—Betamethasone—hematologic cancer	1.61e-05	0.000372	CcSEcCtD
Fluocinonide—Pain—Dexamethasone—hematologic cancer	1.61e-05	0.000372	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—NR0B2—hematologic cancer	1.61e-05	0.000696	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Prednisone—hematologic cancer	1.61e-05	0.000372	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HES1—hematologic cancer	1.61e-05	0.000696	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL10—hematologic cancer	1.6e-05	0.000692	CbGpPWpGaD
Fluocinonide—Skin disorder—Prednisone—hematologic cancer	1.6e-05	0.000368	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL2—hematologic cancer	1.59e-05	0.000687	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CASC3—hematologic cancer	1.59e-05	0.000687	CbGpPWpGaD
Fluocinonide—Rash—Cisplatin—hematologic cancer	1.58e-05	0.000364	CcSEcCtD
Fluocinonide—Dermatitis—Cisplatin—hematologic cancer	1.58e-05	0.000364	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—hematologic cancer	1.58e-05	0.000681	CbGpPWpGaD
Fluocinonide—Erythema—Epirubicin—hematologic cancer	1.57e-05	0.000363	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—GRB2—hematologic cancer	1.57e-05	0.000679	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—hematologic cancer	1.57e-05	0.000677	CbGpPWpGaD
Fluocinonide—Methylprednisolone—ABCB1—hematologic cancer	1.57e-05	0.015	CrCbGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCND1—hematologic cancer	1.55e-05	0.000669	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—JUN—hematologic cancer	1.55e-05	0.000668	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Triamcinolone—hematologic cancer	1.53e-05	0.000354	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.53e-05	0.00066	CbGpPWpGaD
Fluocinonide—Dizziness—Etoposide—hematologic cancer	1.52e-05	0.00035	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PDE4B—hematologic cancer	1.51e-05	0.000654	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR2—hematologic cancer	1.51e-05	0.000654	CbGpPWpGaD
Fluocinonide—Immune system disorder—Doxorubicin—hematologic cancer	1.51e-05	0.000349	CcSEcCtD
Fluocinonide—Dexamethasone—ABCG2—hematologic cancer	1.51e-05	0.0144	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—FGF19—hematologic cancer	1.5e-05	0.000649	CbGpPWpGaD
Fluocinonide—Dizziness—Prednisolone—hematologic cancer	1.5e-05	0.000345	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—PTEN—hematologic cancer	1.5e-05	0.000646	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RAC2—hematologic cancer	1.49e-05	0.000643	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DKK1—hematologic cancer	1.48e-05	0.000638	CbGpPWpGaD
Fluocinonide—Pruritus—Triamcinolone—hematologic cancer	1.47e-05	0.000339	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—STAT5B—hematologic cancer	1.47e-05	0.000633	CbGpPWpGaD
Fluocinonide—Erythema—Doxorubicin—hematologic cancer	1.46e-05	0.000336	CcSEcCtD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOR2—hematologic cancer	1.45e-05	0.000629	CbGpPWpGaD
Fluocinonide—Rash—Etoposide—hematologic cancer	1.45e-05	0.000334	CcSEcCtD
Fluocinonide—Dermatitis—Etoposide—hematologic cancer	1.44e-05	0.000333	CcSEcCtD
Fluocinonide—Headache—Etoposide—hematologic cancer	1.44e-05	0.000331	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—EP300—hematologic cancer	1.43e-05	0.000616	CbGpPWpGaD
Fluocinonide—Rash—Prednisolone—hematologic cancer	1.43e-05	0.000329	CcSEcCtD
Fluocinonide—Dermatitis—Prednisolone—hematologic cancer	1.42e-05	0.000329	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	1.42e-05	0.000328	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—ADCY7—hematologic cancer	1.42e-05	0.000615	CbGpPWpGaD
Fluocinonide—Headache—Prednisolone—hematologic cancer	1.42e-05	0.000327	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CSF2—hematologic cancer	1.4e-05	0.000607	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—hematologic cancer	1.4e-05	0.000605	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—XIAP—hematologic cancer	1.38e-05	0.000598	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—hematologic cancer	1.38e-05	0.000594	CbGpPWpGaD
Fluocinonide—Dizziness—Triamcinolone—hematologic cancer	1.38e-05	0.000317	CcSEcCtD
Fluocinonide—Infection—Methotrexate—hematologic cancer	1.36e-05	0.000315	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—hematologic cancer	1.36e-05	0.000589	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PRKCG—hematologic cancer	1.35e-05	0.000585	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—JAK1—hematologic cancer	1.35e-05	0.000585	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SH2B3—hematologic cancer	1.35e-05	0.000583	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SMARCA4—hematologic cancer	1.35e-05	0.000583	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Methotrexate—hematologic cancer	1.35e-05	0.000311	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—GZMB—hematologic cancer	1.34e-05	0.000579	CbGpPWpGaD
Fluocinonide—Pruritus—Dexamethasone—hematologic cancer	1.34e-05	0.000308	CcSEcCtD
Fluocinonide—Pruritus—Betamethasone—hematologic cancer	1.34e-05	0.000308	CcSEcCtD
Fluocinonide—Skin disorder—Methotrexate—hematologic cancer	1.33e-05	0.000308	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hematologic cancer	1.33e-05	0.000576	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.33e-05	0.000307	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—hematologic cancer	1.32e-05	0.000571	CbGpPWpGaD
Fluocinonide—Rash—Triamcinolone—hematologic cancer	1.31e-05	0.000303	CcSEcCtD
Fluocinonide—Dermatitis—Triamcinolone—hematologic cancer	1.31e-05	0.000302	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—CREB1—hematologic cancer	1.31e-05	0.000566	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CTNNA1—hematologic cancer	1.31e-05	0.000566	CbGpPWpGaD
Fluocinonide—Dexamethasone—NR3C1—hematologic cancer	1.3e-05	0.0125	CrCbGaD
Fluocinonide—Headache—Triamcinolone—hematologic cancer	1.3e-05	0.000301	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HSPB1—hematologic cancer	1.3e-05	0.000562	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EIF4EBP1—hematologic cancer	1.3e-05	0.000562	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL3—hematologic cancer	1.3e-05	0.000562	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—hematologic cancer	1.29e-05	0.000557	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTHLH—hematologic cancer	1.29e-05	0.000556	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SDC1—hematologic cancer	1.29e-05	0.000556	CbGpPWpGaD
Fluocinonide—Infection—Epirubicin—hematologic cancer	1.28e-05	0.000295	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—RB1—hematologic cancer	1.27e-05	0.000549	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—hematologic cancer	1.27e-05	0.000548	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—hematologic cancer	1.27e-05	0.000548	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL2RA—hematologic cancer	1.27e-05	0.000547	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Epirubicin—hematologic cancer	1.26e-05	0.000291	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—hematologic cancer	1.26e-05	0.000543	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTGER4—hematologic cancer	1.25e-05	0.000541	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—hematologic cancer	1.25e-05	0.00054	CbGpPWpGaD
Fluocinonide—Skin disorder—Epirubicin—hematologic cancer	1.25e-05	0.000288	CcSEcCtD
Fluocinonide—Dizziness—Dexamethasone—hematologic cancer	1.25e-05	0.000288	CcSEcCtD
Fluocinonide—Dizziness—Betamethasone—hematologic cancer	1.25e-05	0.000288	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—LCK—hematologic cancer	1.25e-05	0.000538	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—hematologic cancer	1.24e-05	0.000537	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—hematologic cancer	1.24e-05	0.000536	CbGpPWpGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.23e-05	0.000284	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—H3F3A—hematologic cancer	1.22e-05	0.000528	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Prednisone—hematologic cancer	1.21e-05	0.000279	CcSEcCtD
Fluocinonide—Rash—Dexamethasone—hematologic cancer	1.19e-05	0.000275	CcSEcCtD
Fluocinonide—Rash—Betamethasone—hematologic cancer	1.19e-05	0.000275	CcSEcCtD
Fluocinonide—Dermatitis—Dexamethasone—hematologic cancer	1.19e-05	0.000274	CcSEcCtD
Fluocinonide—Dermatitis—Betamethasone—hematologic cancer	1.19e-05	0.000274	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PRKCZ—hematologic cancer	1.19e-05	0.000513	CbGpPWpGaD
Fluocinonide—Headache—Dexamethasone—hematologic cancer	1.18e-05	0.000273	CcSEcCtD
Fluocinonide—Headache—Betamethasone—hematologic cancer	1.18e-05	0.000273	CcSEcCtD
Fluocinonide—Infection—Doxorubicin—hematologic cancer	1.18e-05	0.000273	CcSEcCtD
Fluocinonide—Pain—Methotrexate—hematologic cancer	1.17e-05	0.000271	CcSEcCtD
Fluocinonide—Nervous system disorder—Doxorubicin—hematologic cancer	1.17e-05	0.000269	CcSEcCtD
Fluocinonide—Pruritus—Prednisone—hematologic cancer	1.16e-05	0.000268	CcSEcCtD
Fluocinonide—Skin disorder—Doxorubicin—hematologic cancer	1.16e-05	0.000267	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PARP1—hematologic cancer	1.15e-05	0.000496	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CREB1—hematologic cancer	1.13e-05	0.000489	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FBXW7—hematologic cancer	1.13e-05	0.000488	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—hematologic cancer	1.13e-05	0.000486	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCR4—hematologic cancer	1.11e-05	0.000478	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HDAC2—hematologic cancer	1.11e-05	0.000478	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—hematologic cancer	1.11e-05	0.000478	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6R—hematologic cancer	1.1e-05	0.000477	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	1.1e-05	0.000477	CbGpPWpGaD
Fluocinonide—Pain—Epirubicin—hematologic cancer	1.1e-05	0.000254	CcSEcCtD
Fluocinonide—Dizziness—Prednisone—hematologic cancer	1.09e-05	0.000251	CcSEcCtD
Fluocinonide—Betamethasone—ABCB1—hematologic cancer	1.08e-05	0.0103	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—CBL—hematologic cancer	1.08e-05	0.000466	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL3—hematologic cancer	1.07e-05	0.000461	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CG—hematologic cancer	1.05e-05	0.000455	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTPN1—hematologic cancer	1.05e-05	0.000453	CbGpPWpGaD
Fluocinonide—Rash—Prednisone—hematologic cancer	1.04e-05	0.000239	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PTPN11—hematologic cancer	1.04e-05	0.000447	CbGpPWpGaD
Fluocinonide—Dermatitis—Prednisone—hematologic cancer	1.04e-05	0.000239	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—RASGRP1—hematologic cancer	1.03e-05	0.000446	CbGpPWpGaD
Fluocinonide—Headache—Prednisone—hematologic cancer	1.03e-05	0.000238	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HSP90AA1—hematologic cancer	1.03e-05	0.000444	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SYK—hematologic cancer	1.03e-05	0.000444	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RARS—hematologic cancer	1.02e-05	0.000442	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—hematologic cancer	1.02e-05	0.000441	CbGpPWpGaD
Fluocinonide—Pain—Doxorubicin—hematologic cancer	1.02e-05	0.000235	CcSEcCtD
Fluocinonide—Hypersensitivity—Methotrexate—hematologic cancer	1.01e-05	0.000233	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CREB1—hematologic cancer	1e-05	0.000434	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT1—hematologic cancer	9.92e-06	0.000429	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL2—hematologic cancer	9.82e-06	0.000424	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6R—hematologic cancer	9.79e-06	0.000423	CbGpPWpGaD
Fluocinonide—Pruritus—Methotrexate—hematologic cancer	9.72e-06	0.000224	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—POLR3E—hematologic cancer	9.63e-06	0.000416	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Epirubicin—hematologic cancer	9.47e-06	0.000218	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—hematologic cancer	9.34e-06	0.000404	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAP2K1—hematologic cancer	9.33e-06	0.000403	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—GRB2—hematologic cancer	9.28e-06	0.000401	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CD—hematologic cancer	9.27e-06	0.0004	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFA—hematologic cancer	9.26e-06	0.0004	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PARP1—hematologic cancer	9.26e-06	0.0004	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—CDKN1A—hematologic cancer	9.13e-06	0.000395	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KITLG—hematologic cancer	9.13e-06	0.000394	CbGpPWpGaD
Fluocinonide—Pruritus—Epirubicin—hematologic cancer	9.09e-06	0.00021	CcSEcCtD
Fluocinonide—Dizziness—Methotrexate—hematologic cancer	9.08e-06	0.00021	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—hematologic cancer	8.99e-06	0.000389	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT5A—hematologic cancer	8.92e-06	0.000385	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN2B—hematologic cancer	8.84e-06	0.000382	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Doxorubicin—hematologic cancer	8.76e-06	0.000202	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PIK3R1—hematologic cancer	8.75e-06	0.000378	CbGpPWpGaD
Fluocinonide—Rash—Methotrexate—hematologic cancer	8.66e-06	0.0002	CcSEcCtD
Fluocinonide—Dermatitis—Methotrexate—hematologic cancer	8.65e-06	0.0002	CcSEcCtD
Fluocinonide—Headache—Methotrexate—hematologic cancer	8.6e-06	0.000199	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—CD86—hematologic cancer	8.55e-06	0.000369	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—JAK2—hematologic cancer	8.5e-06	0.000367	CbGpPWpGaD
Fluocinonide—Dizziness—Epirubicin—hematologic cancer	8.5e-06	0.000196	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—HES1—hematologic cancer	8.43e-06	0.000364	CbGpPWpGaD
Fluocinonide—Pruritus—Doxorubicin—hematologic cancer	8.41e-06	0.000194	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—hematologic cancer	8.4e-06	0.000363	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCOR1—hematologic cancer	8.39e-06	0.000362	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CASP3—hematologic cancer	8.38e-06	0.000362	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—TET2—hematologic cancer	8.35e-06	0.000361	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RARA—hematologic cancer	8.35e-06	0.000361	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF1—hematologic cancer	8.29e-06	0.000358	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CSF2—hematologic cancer	8.29e-06	0.000358	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—hematologic cancer	8.23e-06	0.000356	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPLP1—hematologic cancer	8.19e-06	0.000354	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FOXO1—hematologic cancer	8.17e-06	0.000353	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFRB—hematologic cancer	8.16e-06	0.000352	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—hematologic cancer	8.15e-06	0.000352	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—JUN—hematologic cancer	8.14e-06	0.000352	CbGpPWpGaD
Fluocinonide—Rash—Epirubicin—hematologic cancer	8.1e-06	0.000187	CcSEcCtD
Fluocinonide—Dermatitis—Epirubicin—hematologic cancer	8.1e-06	0.000187	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PIK3CB—hematologic cancer	8.08e-06	0.000349	CbGpPWpGaD
Fluocinonide—Headache—Epirubicin—hematologic cancer	8.05e-06	0.000186	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—PDGFRA—hematologic cancer	8.03e-06	0.000347	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAK1—hematologic cancer	8e-06	0.000346	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PRKCG—hematologic cancer	8e-06	0.000346	CbGpPWpGaD
Fluocinonide—Dizziness—Doxorubicin—hematologic cancer	7.86e-06	0.000181	CcSEcCtD
Fluocinonide—NR3C1—Gene Expression—NR0B2—hematologic cancer	7.76e-06	0.000335	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—AR—hematologic cancer	7.74e-06	0.000335	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—hematologic cancer	7.67e-06	0.000331	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—hematologic cancer	7.59e-06	0.000328	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—hematologic cancer	7.56e-06	0.000326	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—EP300—hematologic cancer	7.51e-06	0.000325	CbGpPWpGaD
Fluocinonide—Rash—Doxorubicin—hematologic cancer	7.5e-06	0.000173	CcSEcCtD
Fluocinonide—Dermatitis—Doxorubicin—hematologic cancer	7.49e-06	0.000173	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—IL2RA—hematologic cancer	7.47e-06	0.000323	CbGpPWpGaD
Fluocinonide—Headache—Doxorubicin—hematologic cancer	7.45e-06	0.000172	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—IL2—hematologic cancer	7.42e-06	0.000321	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT3A—hematologic cancer	7.4e-06	0.00032	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TERT—hematologic cancer	7.39e-06	0.000319	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ELL—hematologic cancer	7.3e-06	0.000315	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDGFB—hematologic cancer	7.21e-06	0.000312	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—CDKN2B—hematologic cancer	7.14e-06	0.000308	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	7.11e-06	0.000307	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—hematologic cancer	7.06e-06	0.000305	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TSC2—hematologic cancer	7.05e-06	0.000305	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOR2—hematologic cancer	7e-06	0.000303	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGFR3—hematologic cancer	6.78e-06	0.000293	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NCOR1—hematologic cancer	6.77e-06	0.000292	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK14—hematologic cancer	6.72e-06	0.00029	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—ESR1—hematologic cancer	6.59e-06	0.000285	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FN1—hematologic cancer	6.51e-06	0.000281	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AGO2—hematologic cancer	6.46e-06	0.000279	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BAD—hematologic cancer	6.43e-06	0.000278	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NFKBIA—hematologic cancer	6.43e-06	0.000278	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOTCH1—hematologic cancer	6.37e-06	0.000275	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—DNMT3B—hematologic cancer	6.33e-06	0.000273	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—H3F3B—hematologic cancer	6.33e-06	0.000273	CbGpPWpGaD
Fluocinonide—Dexamethasone—ABCB1—hematologic cancer	6.29e-06	0.00601	CrCbGaD
Fluocinonide—SMO—Signaling Pathways—CD80—hematologic cancer	6.24e-06	0.00027	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KIT—hematologic cancer	6.23e-06	0.000269	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CG—hematologic cancer	6.23e-06	0.000269	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NRAS—hematologic cancer	6.23e-06	0.000269	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTPN11—hematologic cancer	6.12e-06	0.000264	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—hematologic cancer	6.1e-06	0.000263	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAPK3—hematologic cancer	5.96e-06	0.000258	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CREB1—hematologic cancer	5.93e-06	0.000256	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BRAF—hematologic cancer	5.85e-06	0.000253	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL2—hematologic cancer	5.8e-06	0.000251	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPS14—hematologic cancer	5.79e-06	0.00025	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6R—hematologic cancer	5.78e-06	0.00025	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CREBBP—hematologic cancer	5.77e-06	0.000249	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NUP98—hematologic cancer	5.7e-06	0.000246	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—hematologic cancer	5.69e-06	0.000246	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAP2K1—hematologic cancer	5.51e-06	0.000238	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NUP214—hematologic cancer	5.49e-06	0.000237	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CD—hematologic cancer	5.47e-06	0.000237	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—KRAS—hematologic cancer	5.36e-06	0.000232	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ESR1—hematologic cancer	5.32e-06	0.00023	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FGF2—hematologic cancer	5.24e-06	0.000226	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3R1—hematologic cancer	5.17e-06	0.000223	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—NOTCH1—hematologic cancer	5.14e-06	0.000222	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EIF4EBP1—hematologic cancer	5.06e-06	0.000219	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HSPB1—hematologic cancer	5.06e-06	0.000219	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JAK2—hematologic cancer	5.02e-06	0.000217	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PIK3CA—hematologic cancer	4.92e-06	0.000213	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—hematologic cancer	4.92e-06	0.000213	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MDM2—hematologic cancer	4.9e-06	0.000212	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—SMC1A—hematologic cancer	4.84e-06	0.000209	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MTOR—hematologic cancer	4.77e-06	0.000206	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CB—hematologic cancer	4.77e-06	0.000206	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—H3F3A—hematologic cancer	4.75e-06	0.000205	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—CREBBP—hematologic cancer	4.66e-06	0.000201	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HRAS—hematologic cancer	4.56e-06	0.000197	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—EZH2—hematologic cancer	4.55e-06	0.000197	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1B—hematologic cancer	4.48e-06	0.000193	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PARP1—hematologic cancer	4.46e-06	0.000193	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CASP3—hematologic cancer	4.39e-06	0.00019	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2—hematologic cancer	4.38e-06	0.000189	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—hematologic cancer	4.36e-06	0.000188	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HDAC2—hematologic cancer	4.3e-06	0.000186	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCND1—hematologic cancer	4.27e-06	0.000185	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—JUN—hematologic cancer	4.26e-06	0.000184	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1A—hematologic cancer	4.13e-06	0.000179	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTEN—hematologic cancer	4.12e-06	0.000178	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK8—hematologic cancer	4.03e-06	0.000174	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AKT1—hematologic cancer	4.02e-06	0.000174	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EP300—hematologic cancer	3.93e-06	0.00017	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SRC—hematologic cancer	3.82e-06	0.000165	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AR—hematologic cancer	3.73e-06	0.000161	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—hematologic cancer	3.72e-06	0.000161	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—hematologic cancer	3.69e-06	0.000159	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NRAS—hematologic cancer	3.68e-06	0.000159	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK3—hematologic cancer	3.52e-06	0.000152	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CDKN2B—hematologic cancer	3.44e-06	0.000148	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—hematologic cancer	3.43e-06	0.000148	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—hematologic cancer	3.42e-06	0.000148	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NCOR1—hematologic cancer	3.26e-06	0.000141	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—KRAS—hematologic cancer	3.17e-06	0.000137	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PIK3CA—hematologic cancer	2.91e-06	0.000126	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—hematologic cancer	2.81e-06	0.000122	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—hematologic cancer	2.77e-06	0.000119	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HRAS—hematologic cancer	2.69e-06	0.000116	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MAPK14—hematologic cancer	2.61e-06	0.000113	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—hematologic cancer	2.58e-06	0.000111	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ESR1—hematologic cancer	2.56e-06	0.000111	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—NOTCH1—hematologic cancer	2.47e-06	0.000107	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AKT1—hematologic cancer	2.38e-06	0.000103	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CREBBP—hematologic cancer	2.24e-06	9.69e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MAPK3—hematologic cancer	1.37e-06	5.91e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—hematologic cancer	1.33e-06	5.75e-05	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—AKT1—hematologic cancer	9.23e-07	3.99e-05	CbGpPWpGaD
